ipharmaservicesMay 6Atopic dermatitis newsEli Lilly announced the positive results of Phase 3 clinical trial of its drug, lebrikizumab, in treating atopic dermatitis. There was a...
ipharmaservicesMay 4Non-Hodgkin lymphoma news | Breyanzi efficacy in FL and MCLBMS announced that Breyanzi (lisocabtagene maraleucel) met the primary endpoint of the overall response rate in two types of...